NL-OMON42514已完成不适用
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of single and multiple escalating doses of ODM-108: a single centre study in healthy male volunteers. - ODM-108 SAD and MAD study.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 206
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male volunteers
- •18 - 55 years, inclusive
- •BMI 18 - 30 kilograms/meter2
- •Weight 55 - 95 kilograms, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
招募中
不适用
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of single and multiple escalating doses of ODM-111 and effect of food on the pharmacokinetics of ODM-111 and pharmacokinetic drug-drug interaction potential of ODM-111Chronic-/neuropathic pain10029305NL-OMON53911Orion Corporation182
进行中（未招募）
1 期
A study on the safety and effectiveness of the new investigational drug ODM-111 when given to healthy volunteers, and how ODM-111 is absorbed and processed by the human body.ovel treatment against chronic-/neuropathic pain.Nervous System DiseasesISRCTN84512888Orion Corporation (Finland)148
进行中（未招募）
1 期
A research study of how a new medicine NNC0365-3769 (Mim8) works in the body of healthy people and patients with bleeding disorderEUCTR2019-000465-20-ATovo Nordisk A/S94
进行中（未招募）
1 期
Safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple subcutaneous doses of NNC0365-3769 (Mim8) in healthy subjects and in subjects with haemophilia A with or without factor VIII inhibitors (NN7769-4513)severe haemophilia A with or without FVIII inhibitorsJPRN-jRCT2031200136Tsuchiyama Akio82
进行中（未招募）
1 期
A research study of how a new medicine NNC0365-3769 (Mim8) works in the body of healthy people and patients with bleeding disorderHealthy volunteers (Haemophilia A with or without inhibitors)Haemophilia AHaemophilia A with inhibitorsMedDRA version: 20.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10053751Term: Hemophilia A with anti factor VIIISystem Organ Class: 100000004850EUCTR2019-000465-20-GBovo Nordisk A/S82